RemedyMD and GulfStream Bioinformatics Announce Partnership to Offer Translational Research Solutions for 75 New Disease Models

SALT LAKE CITY--(BUSINESS WIRE)--RemedyMD Inc. and GulfStream Bioinformatics Corp., leading providers of clinical and translational research solutions, today announced a partnership to provide researchers with a combination of applications, data and tools that enable unprecedented advances in translational research. RemedyMD is incorporating GulfStream’s 75 disease models into the Investigate™ research software suite. As part of the partnership, RemedyMD is integrating GulfStream’s biospecimen management system, BIGR®, into its Investigate suite of applications.

“The information technology aspect of medical research is hopelessly inefficient. MDs and PhDs spend more time massaging spreadsheets than they do conducting breakthrough research”

“The information technology aspect of medical research is hopelessly inefficient. MDs and PhDs spend more time massaging spreadsheets than they do conducting breakthrough research,” said Gary D. Kennedy, CEO of RemedyMD. “Imagine how the pace of research could be accelerated if a research team started with a pre-built registry that is already populated with relevant disease-specific data elements, and had at their disposal a suite of applications and tools to eliminate their data management burdens. GulfStream’s content and our applications provide all this and more so biomedical researchers can achieve dramatically better results.”

“Researchers who take advantage of this joint offering will find themselves way ahead of the game,” said Kareem Saad, Chief Executive Officer of GulfStream Bioinformatics. “We have spent millions of dollars and nearly 13 person years working with the leading clinicians and scientists to compile the most advanced disease models available. The combination of RemedyMD’s existing software suite with GulfStream’s Disease Specific models and biomaterials management system represent the holy grail for medical researchers.”

Medical researchers are encouraged to visit www.remedymd.com to learn more about the Investigate™ research software suite and see if their research specialty is covered by one of the 75 new disease models.

About RemedyMD

RemedyMD® is a pioneer in the use of predictive informatics to help biomedical and translational researchers recognize patterns and make new discoveries that lead to better medical outcomes and improved research results.

About GulfStream

GSBio® is a life sciences and healthcare information technology services company with specific expertise in the area of translational medicine. GSBio provides its clients with applications, consulting, informatics, and software development to address challenges in clinical data and biospecimen management.